Neurode Secures $3.5M in Pre-Seed Funding to Develop Revolutionary Wearable Headband for ADHD Treatment

Neurode is thrilled to announce a significant funding achievement, having raised $3.5 million in its latest financing round. Renowned for our innovative approach to mental health, we are dedicated to transforming the lives of individuals with ADHD through our groundbreaking wearable headband technology. Designed for convenience and efficacy, our device provides a drug-free solution that allows users to treat and monitor ADHD in just 20 minutes per day, all from the comfort of their homes. The funding will be instrumental in accelerating our product development and enhancing our clinical validation efforts, enabling us to bring our vision to life faster. This investment will bolster our research initiatives, helping us refine our algorithms and showcase the headband's effectiveness in improving focus and attention span. Additionally, it will support our marketing strategies to further engage with the ADHD community and spread awareness about our unique approach. With this new capital, Neurode is poised to contribute to the growing demand for non-pharmaceutical interventions in mental health care, making a marked difference in the day-to-day lives of individuals managing ADHD. As we embark on this next phase of growth, we are excited about the possibilities that lie ahead, and we firmly believe that our technology will revolutionize the way ADHD is understood and treated. Stay tuned for more exciting updates from Neurode as we work to bring our innovative solution to market!